Primary pulmonary hypertension: Immunogenetic response to high-mobility group (HMG) proteins and histone

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 389-395

  Morse, J H ^a   Barst, R J ^a   Fotino, M ^b   Zhang, Y ^b   Flaster, E ^c   Fritzler, M J ^d  

^a College of Physicians and Surgeons ^*  (United States)

^b ROGOSIN INSTITUTE   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

anti HMG antibodies; anti nucleosome; antibodies; autoimmunity; HLA typing; major histocompatibility locus

Indexed keywords

AUTOANTIBODY; HIGH MOBILITY GROUP PROTEIN; HISTONE H1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; HLA SYSTEM; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0029851319     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-848.x     Document Type: Article

References (48)

1. Rich S, Dantzker DR, Ayres SM et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216 23.
2. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 1986; 18:1307 11.
3. Isern RA, Yaneva M, Wiener E, Parke A, Rothfield N, Dantzker D, Rich S. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992; 93:307 12.
4. Rabinovitch M. Autoimmune disease and unexplained pulmonary hypertension. Circulation 1992; 85:380 1.
5. Horn CA. Pulmonary hypertension and autoimmune disease. Chest 1993; 104:279 82.
6. Rawson AJ, Woske HM. A study of etiologic factor in so-called primary pulmonary hypertension. Arch Intern Med 1960; 105:233 43.
7. Morse JH, Barst RJ. Immunologic disturbances in primary pulmonary hypertension. Sem Resp Crit Care Med 1994; 15:222 9.
8. Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995; 129:510 5.
9. Todd GRG, McAteer EJ, Jack CM, Haire M, Roberts SD, Buchanan KD. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill. Ann Rheum Dis 1985;44:266 7.
10. Stupi AM, Steen VD, Owens GR, Barnes L, Rodnan GP, Medsger TA Jr. Primary pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29:515 24.
11. Asherson RA, Morgan SH, Hackett D, Montanes P, Oakley C, Hughes GRV. Rheumatoid arthritis and pulmonary hypertension: a report of three cases. J Rheumatol 1985; 12:154 9.
12. Caldwell IW, Aitchison JD. Pulmonary hypertension in dermatomyositis. Br Heart J 1956; 18:272 6.
13. Graziano FM, Friedman LC, Grossman J. Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathological findings and a review of the literature. Clin Exp Rheumatol 1983; 1:251 5.
14. Theofilopouos AN. The basis of autoimmunity. II Genetic predisposition. Immunol Today 1995; 16:150 9.
15. Langevitz PD, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P. HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 1992; 31:609 13.
16. Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH. Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 1992; 85:249 58.
17. Morse JH, Zhang Y, Fotino M, Barst RJ. Primary pulmonary hypertension (PPH) is associated with HLA-DQ7 (DBQ1*0301) in Caucasians, Circulation 1994; 90:1 149.
18. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 1989; 76:366 72.
19. Gonzalez PJ, Palacian E. Structural and transcriptional properties of different nucleosomal particles containing high mobility group proteins 14 and 17 (HMG 14/17). J Biol Chem 1990; 265:8225 9.
20. Lovell-Badge R. The HMG family of proteins. Nature 1995; 376:725 6.
21. Bustin M, Einck L, Reisch J. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science 1982; 215:1245 7.
22. Ayer LM, Rubin RL, Dixon GH, Fritzler ML. Antibodies to HMG proteins in patients with drug-induced autoimmunity. Arthritis Rheum 1994; 37:98 103.
23. Ayer LM, Senecal J, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group (HMG) proteins in systemic sclerosis. J Rheumatol 1994; 21:2071 5.
24. Neuer G, Bustin M, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to the chromosomal protein HMG-17 in juvenile rheumatoid arthritis. Arthritis Rheum 1992; 35:472 5.
25. Wittemann B, Neuer G, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1990; 33:1378 83.
26. Burlingame RW, Rubin RJ, Rosenberg AM. Autoantibodies to chromatin components in juvenile rheumatoid arthritis. Arthritis Rheum 1993; 36:836 41.
27. Monier JC, Ritter J, Caux C et al. Canine systemic lupus erythematosus II. Antinuclear antibodies Lupus 1992; 1:287 93.
28. D'Alonzo GE, Barst RJ, Ayres A et al. Survival in patients with primary pulmonary hypertension. Result from a national prospective registry. Ann Int Med 1991; 115:343 9.
29. Fritzler MJ, Rubin RL, Drug-induced lupus. In: Dubois EL, Hahn B, Wallace DJ, ed. Dubois' lupus erythematosus. Philadelphia: Lea & Febiger, 1993:442.
30. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271 7.
31. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581 90.
32. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315 24.
33. Cassidy JT, Levinson JF, Brewer EJ. The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis 1989; 38:5.
34. Nicholas RH, Goodwill GH. Isolation and analysis. In. Johns EW, ed. The HMG chromosomal proteins. New York: Academic Press, 1992:41.
35. Olerup O, Zetterquist H. HLA DR typing by amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss Antigens 1992; 39:225 35.
36. SAS Procedures Guide. Cary, NC: SAS Institute, Inc., 1988.
37. Gao X, Sun Y, An J, Fernandez-Vina M, Jinan Q, Lin L, Stastny P. DNA typing for HLA-DR, and -DP alleles in a Chinese population using the polymerase chain reaction (PCR) and oligonucleotide probes. Tiss Antigens 1991; 39:24 30.
38. Fernandez-Vina M, Ramirez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tiss Antigens 1993; 41:57 64.
39. Cerna M, Fernandez-Vina M, Ivaskova E, Stastny P. Comparison of HLA class II alleles in Gypsy and Czech populations by DNA typing with olignucleotide probes. Tiss Antigens 1992; 39:111 6.
40. Martin L, Pauls JD, Ryan JP, Fritzler MJ. Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centreomere and histone. Ann Rheum Dis 1993; 52:780 4.
41. Malleson PN, Fung MY, Petty RE, Mackinnon MJ, Schroeder M-L. Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens. Ann Rheum Dis 1992; 52:1301 6.
42. Arnett FC, Revielle JD, Goldstein R, Pollard KM, Fritzler MJ. Autoantibodies to U3-RNP (Fibrillarin) in systemic sclerosis (SSc): frequencies and immunogenetic studies. Arthritis Rheum 1994; 37:S261.
43. Fritzler MJ. Autoantibodies in scleroderma. J Dermatol 1993; 20:257 68.
44. Barron KS, Silverman ED, Gonzales J, Revielle JD. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993; 36:348-54.
45. Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604.
46. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. Three dimensional structure of human -class II histocompatibility HLA-DR1. Nature 1993; 364:33-39.
47. Bettinott MP, Hartung K, Deicher HRG, Keller E, Mikschl S, Albert E. DR2 haplotypes (DRB1, DQA1, DQB1) associated with systemic lupus erythematosus. Immunogenetics 1993; 38:74-77.
48. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94:184-92.